190 related articles for article (PubMed ID: 2614028)
21. Uterine sarcoma: 14 years experience in KCCC.
Al Wakiel H; Ragheb AM; Varghese A; Juzeer A; Vashista S; Albasmy A
Gulf J Oncolog; 2008 Jul; (4):45-51. PubMed ID: 20084775
[TBL] [Abstract][Full Text] [Related]
22. Uterine malignant mixed mullerian tumors should not be included in studies of endometrial carcinoma.
Vaidya AP; Horowitz NS; Oliva E; Halpern EF; Duska LR
Gynecol Oncol; 2006 Nov; 103(2):684-7. PubMed ID: 16797683
[TBL] [Abstract][Full Text] [Related]
23. Primary ovarian sarcoma: analysis of prognostic variables and the role of surgical cytoreduction.
Sood AK; Sorosky JI; Gelder MS; Buller RE; Anderson B; Wilkinson EJ; Benda JA; Morgan LS
Cancer; 1998 May; 82(9):1731-7. PubMed ID: 9576296
[TBL] [Abstract][Full Text] [Related]
24. [Uterine sarcoma. Retrospective analysis of a series of 22 cases].
Mage P; Chauvergne J; Bui NB; Avril A; Trojani M; Richaud P; Germain T; Maree D
J Gynecol Obstet Biol Reprod (Paris); 1984; 13(7):802-7. PubMed ID: 6549321
[TBL] [Abstract][Full Text] [Related]
25. Treatment of maxillary sinus carcinoma: a comparison of the 1997 and 1977 American Joint Committee on cancer staging systems.
Le QT; Fu KK; Kaplan M; Terris DJ; Fee WE; Goffinet DR
Cancer; 1999 Nov; 86(9):1700-11. PubMed ID: 10547542
[TBL] [Abstract][Full Text] [Related]
26. Outcome after combined modality treatment for uterine papillary serous carcinoma: a study by the Rare Cancer Network (RCN).
Goldberg H; Miller RC; Abdah-Bortnyak R; Steiner M; Yildiz F; Meirovitz A; Villà S; Poortmans PM; Azria D; Zidan J; Ozsahin M; Abacioglu U; Gold DG; Amit A; Lavie O; Atahan IL; Kuten A;
Gynecol Oncol; 2008 Feb; 108(2):298-305. PubMed ID: 18096209
[TBL] [Abstract][Full Text] [Related]
27. [Purely mesenchymal homologous uterus sarcomas (leiomyosarcomas and endometrial stroma sarcomas) at the Zurich University Gynecologic Hospital].
Bronz L; Genton CY; Kunz J; Schreiner WE
Geburtshilfe Frauenheilkd; 1985 May; 45(5):288-93. PubMed ID: 4007466
[TBL] [Abstract][Full Text] [Related]
28. The role of surgery and treatment trends in uterine sarcoma.
Benoit L; Arnould L; Cheynel N; Goui S; Collin F; Fraisse J; Cuisenier J
Eur J Surg Oncol; 2005 May; 31(4):434-42. PubMed ID: 15837053
[TBL] [Abstract][Full Text] [Related]
29. Uterine leiomyosarcoma: analysis of treatment failures and survival.
Gadducci A; Landoni F; Sartori E; Zola P; Maggino T; Lissoni A; Bazzurini L; Arisio R; Romagnolo C; Cristofani R
Gynecol Oncol; 1996 Jul; 62(1):25-32. PubMed ID: 8690287
[TBL] [Abstract][Full Text] [Related]
30. Uterine endolymphatic stromal myosis: a collaborative study.
Piver MS; Rutledge FN; Copeland L; Webster K; Blumenson L; Suh O
Obstet Gynecol; 1984 Aug; 64(2):173-8. PubMed ID: 6738952
[TBL] [Abstract][Full Text] [Related]
31. [Management of soft tissue sarcomas in first isolated local recurrence: a retrospective study of 83 cases].
Moureau-Zabotto L; Thomas L; Bui BN; Chevreau C; Stockle E; Martel P; Bonneviale P; Marques B; Coindre JM; Kantor G; Matsuda T; Delannes M
Cancer Radiother; 2004 Oct; 8(5):279-87. PubMed ID: 15561593
[TBL] [Abstract][Full Text] [Related]
32. [Prognostic factors in adenocarcinoma of the endometrium].
Giordana C; Malinverni G; Rosmino C; Del Tetto F; Ravarino N; Sala S
Radiol Med; 1991 Mar; 81(3):342-5. PubMed ID: 2014343
[TBL] [Abstract][Full Text] [Related]
33. Flow cytometric analysis of uterine sarcomas.
Lennart K; Lennart B; Ulf S; Bernard T
Gynecol Oncol; 1994 Dec; 55(3 Pt 1):339-42. PubMed ID: 7835771
[TBL] [Abstract][Full Text] [Related]
34. [Prognostic factors in cancer of the endometrium and therapeutic indications].
Fossat C; Mage P; Marée D; Avril A; Pigneux J; Richaud P
J Gynecol Obstet Biol Reprod (Paris); 1984; 13(5):573-8. PubMed ID: 6491199
[TBL] [Abstract][Full Text] [Related]
35. [Sarcoma of the uterus. A clinical study apropos of 50 surgically treated cases at the Gustave Roussy Institute. Review of the literature].
Michel G; Pfeiffer F; Duvillard P; Prade M; Castaigne D; Zarca D; Pejovic-Lenfant MH; Gerbaulet A; Lhomme C
J Gynecol Obstet Biol Reprod (Paris); 1989; 18(8):1024-30. PubMed ID: 2695569
[TBL] [Abstract][Full Text] [Related]
36. The management of patients with uterine sarcoma: a debated clinical challenge.
Gadducci A; Cosio S; Romanini A; Genazzani AR
Crit Rev Oncol Hematol; 2008 Feb; 65(2):129-42. PubMed ID: 17706430
[TBL] [Abstract][Full Text] [Related]
37. [Effort to radically cure stage III and IV esophageal carcinoma with simultaneous radiotherapy and chemotherapy in standard clinical practice].
Farzad M; De Luca MC; Rubino G; Pirtoli L; Pepi F; Sebaste L; Ponticelli P; Atzeni G; Maranzano E; Silvano G
Radiol Med; 2001; 102(1-2):72-7. PubMed ID: 11677442
[TBL] [Abstract][Full Text] [Related]
38. Limitations of adjuvant radiotherapy for uterine sarcomas spread beyond the uterus.
Dusenbery KE; Potish RA; Judson P
Gynecol Oncol; 2004 Jul; 94(1):191-6. PubMed ID: 15262141
[TBL] [Abstract][Full Text] [Related]
39. Uterine sarcoma: prognostic factors and treatment evaluation.
Naaman Y; Shveiky D; Ben-Shachar I; Shushan A; Mejia-Gomez J; Benshushan A
Isr Med Assoc J; 2011 Feb; 13(2):76-9. PubMed ID: 21443030
[TBL] [Abstract][Full Text] [Related]
40. Postoperative radiotherapy in the treatment of uterine sarcomas: long-term results and analysis of prognostic factors.
Sahinler I; Atalar B; Tecer GM; Calay Z; Koca S; Atkovar G; Okkan S
J BUON; 2010; 15(3):480-8. PubMed ID: 20941814
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]